A Diversified Library of Bacterial and Fungal Bifunctional Cytochrome P450 Enzymes for Drug Metabolite Synthesis
- 21 September 2009
- journal article
- research article
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 351 (13) , 2140-2146
Abstract
Innovative biohydroxylation catalysts for the preparation of drug metabolites were developed from scratch. A set of bacterial and fungal sequences of putative and already known bifunctional P450 enzymes was identified by protein sequence alignments, expressed in Escherichia coli and characterised. Notably, a fungal self‐sufficient cytochrome P450 (CYP) from Aspergillus fumigatus turned out to be especially stable during catalyst preparation and application and also in presence of organic co‐solvents. To enhance the catalytic activity and broaden the substrate specificity of those variants with high expression levels prominent single mutations were introduced. Selected improved variants were then used as lyophilised bacterial lysates for the synthesis of 4′‐hydroxydiclofenac and 6‐hydroxychlorzoxazone, the two metabolites of active pharmaceutical compounds diclofenac and chlorzoxazone representing the same metabolites as generated by human P450s.Keywords
This publication has 49 references indexed in Scilit:
- Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolitesChemico-Biological Interactions, 2008
- Engineering of Artificial Plant Cytochrome P450 Enzymes for Synthesis of Isoflavones by Escherichia coliApplied and Environmental Microbiology, 2007
- Engineering and Analysis of a Self-Sufficient Biosynthetic Cytochrome P450 PikC Fused to the RhFRED Reductase DomainJournal of the American Chemical Society, 2007
- Biocatalytic Conversion of Avermectin to 4″-Oxo-Avermectin: Improvement of Cytochrome P450 Monooxygenase Specificity by Directed EvolutionApplied and Environmental Microbiology, 2007
- Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymesJBIC Journal of Biological Inorganic Chemistry, 2007
- Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3Biochemical and Biophysical Research Communications, 2006
- Protein stability promotes evolvabilityProceedings of the National Academy of Sciences, 2006
- Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coliJournal of Industrial Microbiology and Biotechnology, 2005
- Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coliFEBS Letters, 1996
- Protein folding in the central cavity of the GroEL–GroES chaperonin complexNature, 1996